Author:
Tejeda Ramírez Sol,Tardáguila-García Aroa,López-Moral Mateo,Sanz-Corbalán Irene,García-Madrid Marta,Lázaro-Martínez José Luis
Abstract
ABSTRACT
OBJECTIVE
To evaluate the cost-effectiveness of two 10% urea creams in patients with diabetic foot syndrome.
METHODS
This was a prospective, longitudinal, single-center, randomized, double-blind, prospective clinical trial that evaluated the skin quality of 20 feet belonging to 10 patients with diabetic foot syndrome after the application of two 10% urea creams purchased from pharmacies and supermarkets.
RESULTS
At follow-up, 19 (95%) of the participants’ feet showed improved skin quality, irrespective of the cream applied. On visual inspection, participants had a decreased presence of xerosis, hyperkeratosis, and preulcerative signs such as subkeratotic bruising and areas of redness on the dorsum of the toes. At the 3-month follow-up, nine (90%) of the participants stated that they had continued to apply the cream as a method of self-management to prevent complications.
CONCLUSIONS
Creams containing 10% urea purchased in supermarkets improve foot skin quality in patients with diabetic foot syndrome, regardless of their cost. Based on these findings, the authors recommend creams containing 10% urea as a self-management tool for patients with diabetic foot syndrome.
Publisher
Ovid Technologies (Wolters Kluwer Health)